Skip to content

Clinical study of heat-sensitive moxibustion to reduce drug craving in methamphetamine users : a randomized controlled trial

Research and development of intelligent key technology and equipment of variable frequency moxibustion for obtaining gas and its demonstration application

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000539
Enrollment
Unknown
Registered
2025-03-17
Start date
2025-05-06
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methamphetamine addiction cravings

Interventions

Heat sensitive moxibustion group :The heat sensitive moxibustion robot was used to move repeatedly at a specific rate in Shenque and Danzhong points. When Deqi sensation occurred the operation of the
false moxibustion group:The heat sensitive moxibustion robot was used to move repeatedly at a specific rate in Shenque and Shanzhong points. The moxibustion temperature was determined by the slight he

Sponsors

The Affiliated Hospital of Jiangxi University of CM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria for MA dependence in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V); 2) Age 18-65 years old; (3) more than 6 years of education; (4) No other drug or non-drug therapeutic intervention during treatment; 5) simple use of methamphetamine; 6) First time into the compulsory drug rehabilitation center there is a psychological need for drug rehabilitation; 7) The subject is willing to be tested and can complete the prescribed time of heat-sensitive moxibustion; 8) can correctly express the qi sensation; 9) The 3-month physiological detoxification period has been completed and no detoxification has been completed during the test; 10) Shenque point and Danzhong point heat sensitivity.

Exclusion criteria

Exclusion criteria: 1)A serious physical or neurological disease that requires medication such as diabetes stroke epilepsy trauma etc.; 2) suffering from mental disorders such as bipolar disorder schizophrenia etc.; (3) suffering from infectious diseases such as AIDS and tuberculosis; Dependence on substances other than nicotine and alcohol in the past 5 years; (5) Pregnant or lactating; 6) Received moxibustion treatment in the past 1 month; 7) Participate in other clinical investigators at the same time.

Design outcomes

Primary

MeasureTime frame
Visual analog scale Score;

Secondary

MeasureTime frame
Pittsburgh sleep quality index;Eeg evaluation of sleep effect in moxibustion;Evaluation of Deqi in moxibustion;Analysis of near-infrared brain function imaging;Hamilton Depression Scale Score;Hamilton Anxiety Scale Score;

Countries

China

Contacts

Public ContactDingyi Xie.Rixin Chen

The Affiliated Hospital of Jiangxi University of CM

281999814@qq.com+86 13970850489

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026